First AAV gene therapy poised for landmark approval, Nat Biotechnol, vol.35, pp.998-1007, 2017. ,
Gene therapy in a large animal model of PDE6A-retinitis pigmentosa, Front Neurosci, vol.11, 2017. ,
Gene supplementation rescues rod function and preserves photoreceptor and retinal morphology in dogs, leading the way toward treating human PDE6A-retinitis pigmentosa, Hum Gene Ther, vol.28, pp.1189-201, 2017. ,
AAV-mediated gene therapy halts retinal degeneration in PDE6?-deficient dogs, Mol Ther, vol.24, pp.867-76, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01798999
Development of a gene-therapy vector for RDH12-associated retinal dystrophy, Hum Gene Ther, vol.30, 2019. ,
AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice, Mol Ther Methods Clin Dev, vol.2, p.15022, 2015. ,
Gene therapy fully restores vision to the all-cone Nrl(-/-) Gucy2e(-/-) mouse model of Leber congenital amaurosis-1, Hum Gene Ther, vol.26, pp.575-92, 2015. ,
AAV8(Y733F)-mediated gene therapy in a Spata7 knockout mouse model of Leber congenital amaurosis and retinitis pigmentosa, Gene Ther, vol.22, pp.619-646, 2015. ,
Gene therapy using a miniCEP290 fragment delays photoreceptor degeneration in a mouse model of Leber congenital amaurosis, Hum Gene Ther, vol.29, pp.42-50, 2018. ,
A CEP290 C-terminal domain complements the mutant CEP290 of Rd16 mice In trans and rescues retinal degeneration, Cell Rep, vol.25, pp.611-634, 2018. ,
In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery, Hum Mol Genet, vol.25, pp.2552-63, 2016. ,
Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial, Hum Genet, vol.135, pp.327-370, 2016. ,
Long-term effects of gene therapy in a novel mouse model of human MFRP-associated retinopathy, Hum Gene Ther, vol.30, pp.632-50, 2019. ,
AAV-mediated clarin-1 expression in the mouse retina: implications for USH3A gene therapy, PLoS One, vol.11, p.148874, 2016. ,
Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa, Mol Ther, vol.25, pp.1854-65, 2017. ,
A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration, Hum Mol Genet, vol.24, pp.3956-70, 2015. ,
Development of a molecularly stable gene therapy vector for the treatment of RPGR-associated X-linked retinitis pigmentosa, Hum Gene Ther, vol.30, 2019. ,
Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations, Mol Ther, vol.25, pp.1866-80, 2017. ,
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector, Proc Natl Acad Sci, vol.115, pp.8547-56, 2018. ,
Rhodopsin targeted transcriptional silencing by DNA-binding, eLife, vol.5, p.12242, 2016. ,
Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15, JCI Insight, vol.2, p.96560, 2017. ,
Somatic gene editing of GUCY2D by AAV-CRISPR/Cas9 alters retinal structure and function in mouse and macaque, Hum Gene Ther, vol.30, pp.571-89, 2019. ,
Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa, Mol Ther, vol.19, pp.642-651, 2011. ,
Long-term photoreceptor rescue in two rodent models of retinitis pigmentosa by adeno-associated virus delivery of Stanniocalcin-1, Exp Eye Res, vol.165, pp.175-81, 2017. ,
Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration, J Clin Invest, vol.125, pp.105-121, 2015. ,
, pigmentosa and discuss the technological, economic and ethical chal
, Michel Weber est consultant pour Novartis. Michel Weber et Guylène Le Meur sont actionnaires fondateurs de Horama
Non-syndromic retinitis pigmentosa, Prog Retin Eye Res, vol.66, pp.157-86, 2018. ,
Optogenetic approaches to vision restoration, Exp Eye Res, vol.178, pp.15-26, 2019. ,
Stimulation of functional neuronal regeneration from Müller glia in adult mice, Nature, vol.548, pp.103-110, 2017. ,
Intégration des vecteurs AAV et mutagenèse insertionnelle, Med Sci (Paris), vol.32, pp.167-74, 2016. ,
Superior retinal gene transfer and biodistribution profile of subretinal versus intravitreal delivery of AAV8 in nonhuman primates, Invest Ophthalmol Vis Sci, vol.58, pp.5792-801, 2017. ,
La conception de vecteurs adaptés à la thérapie génique oculaire, Med Sci. (Paris), vol.31, pp.529-566, 2015. ,
Gene therapy for RPE65-related retinal disease, Ophthalmic Genet, vol.39, pp.671-678, 2018. ,
Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions, J Am Assoc Pediatr Ophthalmol Strabismus, vol.13, pp.587-92, 2009. ,
Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness, Mol Ther, vol.12, pp.1072-82, 2005. ,
Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer, Mol Ther, vol.16, pp.458-65, 2008. ,
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium, Gene Ther, vol.14, pp.292-303, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-02666207
Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection, Mol Ther, vol.13, pp.1074-84, 2006. ,
Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years, Arch Ophthalmol, vol.130, pp.9-24, 2012. ,
Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis, Mol Ther, vol.26, pp.256-68, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01785885
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial, Lancet, vol.388, pp.661-72, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02880968
Effect of gene therapy on visual function in Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2231-2240, 2008. ,
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial, Lancet, vol.390, pp.849-60, 2017. ,
AAV cis-regulatory sequences are correlated with ocular toxicity, Proc Natl Acad Sci, vol.116, pp.5785-94, 2019. ,
Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain, Mol Ther, vol.11, pp.275-83, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02681771
Improvement and decline in vision with gene therapy in childhood blindness, N Engl J Med, vol.372, pp.1920-1926, 2015. ,
Long-term effect of gene therapy on Leber's congenital amaurosis, N Engl J Med, vol.372, pp.1887-97, 2015. ,
Macular fold complicating a subretinal injection of voretigene neparvovec, Ophthalmol Retina, 2019. ,
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression, J Clin Invest, vol.130, 2019. ,
Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases, Hum Genet, vol.137, pp.679-88, 2018. ,
In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa, Mol Ther, vol.24, pp.556-63, 2016. ,
Concise review: human induced pluripotent stem cell models of retinitis pigmentosa, Stem Cells, vol.36, pp.474-81, 2018. ,
Cost utility of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease, Value Health, vol.22, pp.161-168, 2019. ,
All-optical recording and stimulation of retinal neurons in vivo in retinal degeneration mice, PLoS One, vol.13, p.194947, 2018. ,
Noninvasive gene delivery to foveal cones for vision restoration, JCI Insight, vol.3, p.96029, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01718061
L'innovation thérapeutique, à quel prix ?, Med Sci (Paris), vol.36, pp.389-93, 2020. ,
Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas, Nature, vol.560, pp.484-492, 2018. ,
Stimulation of functional neuronal regeneration from Müller glia in adult mice, Nature, vol.548, pp.103-110, 2017. ,
Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter, EMBO Mol Med, vol.6, pp.1175-90, 2014. ,
Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol Med, vol.8, pp.1248-64, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01375637